Title : BRAF and NRAS mutations in melanoma: potential relationships to clinical response to HSP90 inhibitors.

Pub. Date : 2008 Apr

PMID : 18375819






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 BRAF that is activated by the common V600E and other mutations, as well as by upstream NRAS mutations, has been shown to require the molecular chaperone heat shock protein 90 (HSP90) for stabilization and is depleted by the HSP90 inhibitor 17-allylamino-17-demethoxygeldanamycin (17-AAG)]. tanespimycin B-Raf proto-oncogene, serine/threonine kinase Homo sapiens